Información del producto
BPAM-344 is a new class of agent that has been developed for the treatment of Alzheimer's disease. It has shown low toxicity and good pharmacokinetics in animal studies. BPAM-344 is an ionotropic glutamate receptor antagonist that prevents glutamate from binding to the receptor and activating it. This agent also has the ability to block or prevent the development of tolerance to low doses of x-ray radiation, which may be due to its ability to inhibit structural changes in DNA caused by radiation exposure. The structural analysis of this drug revealed a novel molecular scaffold that is different from other agents in its class. A fluorescence assay confirmed that BPAM-344 binds tightly with aluminum oxide, which may be used as a potential adjuvant for this drug.
Propiedades químicas
Consulta técnica sobre: 3D-EYB57255 BPAM-344
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
